FDA committee considers Gardasil for anal cancer prevention

The human papillomavirus vaccine Gardasil moved closer to an indication for anal cancer prevention after a meeting of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee on Nov. 17.

The vaccine, manufactured by Merck & Co. Inc., is

New chemotherapeutic agent approved for use in late-stage breast cancer

On November 15, 2010, the US Food and Drug Administration announced the approval of Halaven (eribulin mesylate) for the treatment of patients with metastatic breast cancer who have received at least 2 prior chemotherapy regimens for late-stage disease.

FDA approves trastuzumab for HER2-positive gastric cancer

The Food and Drug Administration has approved trastuzumab, along with chemotherapy, to treat metastatic HER2-positive gastric cancers in people who have not been previously treated for metastatic disease.
The agency’s decision, announced

Tai chi boosts quality of life in heart failure patients

Patients with chronic systolic heart failure who were enrolled in a 12-week tai chi program experienced significant improvements in quality of life, mood, and exercise self-efficacy, compared with patients who were

New Cancer therapy Put an End to Chemotherapy

Scientists have developed a new cancer treatment that can safely deliver extremely high chemotherapy doses with minimal side effects.
Excited scientists say the new-generation drug, to be announced at a leading cancer conference this week, could be used effectively against many types of tumour, reports the Daily Express.

New Cancer therapy Put an End to Chemotherapy

Elevated chloride levels predict 30-day mortality in Clostridium difficile infections

BY NEIL OSTERWEIL
BOSTON (EGMN) – Hyperchloremia in patients with Clostridium difficile infections is an indicator of disease severity and a risk factor for death within 30 days, according to

Growth Hormone May Benefit Lungs in cystic fibrosis

In patients with cystic fibrosis, recombinant human growth hormone not only has beneficial effects on weight and height but also on many pulmonary measures, researchers reported.

Test to detect your Child Talent Via DNA

The advancement in technology states that a child’s talent can be determined with the aid of DNA testing.
The tests in Europe and the United States are being done in order to discover what the future prospects are. The procedure is said to have few pros and cons which can be elucidated if pondered neck deep into it.
The report stated by Mike Weinstein of Atlas Sports Genetics says, “A child can be tested directly right after they’re born. Because of this in-depth gene mapping knowledge we can determine the inborn or natural talents of your child.”

Nobel Prize in Medicine awarded for IVF fertilization

Robert Edwards has been awarded the 2010 Nobel Prize for the development of human in vitro fertilization (IVF) therapy. His achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity including more than 10% of all couples worldwide.

Nobel Prize in Medicine awarded for IVF fertilization

Ginseng improves working memory in young adults

American ginseng significantly improved working-memory performance in a double-blind, placebo-controlled crossover study of healthy young adults presented at the annual congress of the European College of Neuropsychopharmacology.

unapproved forms of colchicine is banned by FDA

Companies that manufacture, distribute, and/or market unapproved formulations of the oral, single ingredient forms of the gout drug colchicine have been ordered to

No Risk from Delayed Appendectomy

Appendectomies are the most common emergent medical procedure worldwide -- but delaying emergency appendectomy for 12 hours or more appears to have no adverse effects on 30-day outcomes, according to a retrospective review of almost 33,000 cases

IUD May Be Therapy for Endometrial Cancer

An intrauterine contraceptive device -- impregnated with the progestin levonorgestrel -- may successfully treat atypical endometrial hyperplasia and early stage endometrial cancer in young women while preserving their fertility, according to a small prospective study.

Gilenya get approved as a oral treatment for multiple sclerosis

On September 22, 2010, Novartis announced that the US Food and Drug Administration (FDA) has approved Gilenya (fingolimod) as a first-line treatment for relapsing forms of multiple sclerosis (MS). According to Novartis, Gilenya is the first

FDA approves new intravenous gout treatment

On September 14, 2010, Savient Pharmaceuticals and the US Food and Drug Administration (FDA) announced the approval of Krystexxa (pegloticase), an intravenous (IV) treatment for chronic gout in adults whose conditions have been refractory to conventional therapy. Krystexxa is a pegylated uric-acid–specific enzyme that

Darbepoetin worsens 5-year survival in head and neck cancer

The erythropoiesis-stimulating agent darbepoetin alfa should not be used in combination with radiotherapy in patients with potentially curable head and neck cancer, late results of the halted Danish Head and Neck Cancer Study Group 10 trial indicate

Anti-VEGF drug may improve choroidal neovascularization in multifocal choroiditis

Intravitreal bevacizumab appears to be more effective than photodynamic therapy at restoring functional vision in patients with subfoveal choroidal neovascularization secondary to multifocal choroiditis, according to new

Dorzolamide may improve macular lesions in patients with retinitis pigmentosa, Usher’s syndrome

Use of topical dorzolamide may offer to improve cystic macular lesions in patients with retinitis pigmentosa or Usher’s syndrome, and may offer possible improvement in visual acuity, according to a

Baclofen may effectively treat alcohol dependence

The gamma-aminobutryric acid (GABA) receptor agonist baclofen, which is indicated for the treatment of spasticity, might represent a novel and effective drug treatment for alcohol dependence, according to an addiction specialist who presented evidence for this at

Vaginal brachytherapy improves 5-year quality of life in endometrial cancer

Vaginal brachytherapy for high-intermediate risk endometrial cancer is associated with significantly less diarrhea and fewer bowel symptoms that limit patients’ daily activities, compared with pelvic external beam radiation therapy, according to 5-year follow-up data from a phase III trial.
The latest findings from the open-label, randomized